Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy
NCT01223742 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2010-10-19
Summary
The aim of this study was to evaluate the effect of exogenous ALC on the both physical and mental fatigue in mild and moderate encephalopatic patients.
Conditions
- Hepatic Encephalopathy
Interventions
- DIETARY_SUPPLEMENT
-
ACETYL-L-CARNITINE
2 g acetylcarnitine taken orally twice a day.
- DRUG
-
placebo twice per day
Sponsors & Collaborators
-
University of Catania
lead OTHER
Eligibility
- Min Age
- 40 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-06-30
- Completion
- 2006-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Carnitine and Liver Mitochondria Fatty Acid Processing
NCT03193125 ·Status: COMPLETED ·Phase: NA
-
Effect of Acetyl-L-carnitine on Chronic Pancreatitis
NCT02538146 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients
NCT01742013 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity
NCT03564002 ·Status: UNKNOWN
-
Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.
NCT05093218 ·Status: UNKNOWN ·Phase: NA
-
S-adenosylmethionine Plus Choline in Treatment of Patients With Alcoholic Liver Disease
NCT03938662 ·Status: UNKNOWN ·Phase: NA
-
Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma
NCT03908255 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis
NCT02024295 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
NCT01934777 ·Status: COMPLETED ·Phase: PHASE3
-
Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
NCT03420482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Impact Of Choline in Patients With NAFLD
NCT05200156 ·Status: UNKNOWN ·Phase: NA
-
AST-120 Used to Treat Mild Hepatic Encephalopathy
NCT00867698 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids
NCT00328159 ·Status: COMPLETED ·Phase: NA
-
REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID
NCT05840237 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of N-acetyl Cysteine, Acetyl L- Carnitine and Medicated Paraffin Oil in Aluminium Phosphide Poisoning
NCT04509258 ·Status: UNKNOWN ·Phase: PHASE4
-
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
NCT06538077 ·Status: RECRUITING ·Phase: PHASE4
-
Quality of Life and Nutritional Improvements in Cirrhotic Patients
NCT01842113 ·Status: TERMINATED ·Phase: PHASE4
-
Total Parenteral Nutrition-Associated Liver Disease
NCT00031135 ·Status: TERMINATED ·Phase: PHASE2
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease
NCT05578404 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency
NCT04147936 ·Status: COMPLETED ·Phase: NA
-
N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure
NCT00248625 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374 ·Status: COMPLETED ·Phase: PHASE1
-
A Feasibility Trial of OCM Supplements for the Treatment of NAFLD
NCT05720702 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy
NCT06072521 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2